RETRACTED ARTICLE: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

A core gut microbiome in obese and lean twins

Peter J. Turnbaugh, Micah Hamady, Tanya Yatsunenko et al. · Nature · 2008 · 7.8K citations · Full text

Obesity, Nutrition, Dysbiosis +9

Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform

James J. Kozich, Sarah L. Westcott, Nielson T. Baxter et al. · Applied and Environmental Microbiology · 2013 · 7.2K citations · Full text

Genetics, Curation Pipeline, Genomics +21

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

Patrice D. Cani, Sam Possemiers, Tom Van de Wiele et al. · Gut · 2009 · 2.4K citations · Full text

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

Yun Kyung Lee, Juscilene S. Menezes, Yoshinori Umesaki et al. · Proceedings of the National Academy of Sciences · 2010 · 1.3K citations

Rifaximin Treatment in Hepatic Encephalopathy

Nathan M. Bass, Kevin D. Mullen, Arun J. Sanyal et al. · New England Journal of Medicine · 2010 · 1.2K citations